stella
beta
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma — Stella
Recruiting
Back to Rhabdomyosarcoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
National Institutes of Health Clinical Center, Bethesda, Maryland
View full record on ClinicalTrials.gov